Nano X ImagingNNOX
NNOX
0
Funds holding %
of 6,780 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
33% more call options, than puts
Call options by funds: $15.7M | Put options by funds: $11.8M
26% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 27
13% more funds holding
Funds holding: 103 [Q2] → 116 (+13) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
1.8% less ownership
Funds ownership: 20.12% [Q2] → 18.32% (-1.8%) [Q3]
24% less capital invested
Capital invested by funds: $85.3M [Q2] → $65.1M (-$20.2M) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$11
80%
upside
Avg. target
$12.50
105%
upside
High target
$14
129%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Cantor Fitzgerald Ross Osborn 58% 1-year accuracy 21 / 36 met price target | 80%upside $11 | Overweight Maintained | 26 Nov 2024 |
Cantor Fitzgerald Ross Osborn 58% 1-year accuracy 21 / 36 met price target | 129%upside $14 | Overweight Reiterated | 23 Sept 2024 |
Financial journalist opinion
Neutral
Seeking Alpha
1 week ago
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Scott Henry - Alliance Global Operator Ladies and gentlemen, thank you for standing by.
Neutral
GlobeNewsWire
3 weeks ago
Nanox to Report Third Quarter and Financial Results on November 21, 2024
PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Neutral
GlobeNewsWire
1 month ago
Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions
Nanox AI's Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas
Neutral
GlobeNewsWire
2 months ago
Nanox to Participate in Upcoming Investor Conference in September 2024
PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company management will participate in an investor conference in the month of September 2024:
Neutral
Zacks Investment Research
3 months ago
Here's Why NanoX Imaging (NNOX) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for NanoX Imaging (NNOX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Neutral
GlobeNewsWire
3 months ago
Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium
HealthCCSng V2.0 i ntroduces additional ‘ zero calcium ' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC d etection c ategory output
Neutral
Seeking Alpha
3 months ago
Nano-X Imaging Ltd. (NNOX) Q2 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q2 2024 Earnings Conference Call August 20, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Scott Henry - AGP Ross Osborn - Cantor Fitzgerald Operator Good day, and thank you for standing by.
Neutral
GlobeNewsWire
3 months ago
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand Nanox.ARC indications to include general use, including chest Nanox.AI Receives FDA 510K Clearance for HealthCCSng V 2.0, upgraded version of its AI Cardiac Solution Management to host conference call and webcast Tuesday, August 20, 2024 at 8:30 AM ET PETAH TIKVA, Israel, Aug. 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2024 and provided a business update. Recent Highlights: Generated $2.7 million in revenue in the second quarter of 2024, compared to $2.6 million in the second quarter of 2023.
Negative
The Motley Fool
3 months ago
3 Artificial Intelligence (AI) Stocks That Could Go Parabolic
Nanox relies on AI to better interpret patients' scans. Reducing fraud for e-commerce companies is at the core of Riskified's business.
Neutral
GlobeNewsWire
3 months ago
Nanox to Report Second Quarter and Financial Results on August 20, 2024
PETACH TIKVA, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2024, before market open on Tuesday, August 20, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Charts implemented using Lightweight Charts™